A simple measurement of plasma platelet-activating factor (PAF) acetylhydrolase, normal level of activity, and distribution among lipoprotein fractions
Kawamura, Y.; Satoh, K.; Takamatsu, S.; Mizuno, S.
Rinsho Byori. Japanese Journal of Clinical Pathology 35(10): 1149-1153
1987
ISSN/ISBN: 0047-1860 PMID: 3437547 Document Number: 294463
Document emailed within 1 workday
Related Documents
Tsukioka, K.; Matsuzaki, M.; Nakamata, M.; Kayahara, H.; Nakagawa, T. 1996: Increased plasma level of platelet-activating factor (PAF) and decreased serum PAF acetylhydrolase (PAFAH) activity in adults with bronchial asthma Journal of Investigational Allergology and Clinical Immunology 6(1): 22-29Kobayashi, F.; Sagawa, N.; Ihara, Y.; Kitagawa, K.; Yano, J.; Mori, T. 1994: Platelet-activating factor-acetylhydrolase activity in maternal and umbilical venous plasma obtained from normotensive and hypertensive pregnancies Obstetrics and Gynecology 84(3): 360-364
Takashima, M.; Yasuda, K.; Umesaki, K.; Nakajima, T.; Sawaragi, I. 1994: Effects of estrogen and progestin on platelet-activating factor acetylhydrolase Nihon Sanka Fujinka Gakkai Zasshi 46(6): 481-488
Liberopoulos, E.N.; Papavasiliou, E.; Miltiadous, G.A.; Cariolou, M.; Siamopoulos, K.C.; Tselepis, A.D.; Elisaf, M.S. 2004: Alterations of paraoxonase and platelet-activating factor acetylhydrolase activities in patients on peritoneal dialysis Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 24(6): 580-589
Hwang, S.B.; Li, C.L.; Lam, M.H.; Shen, T.Y. 1985: Characterization of cutaneous vascular permeability induced by platelet-activating factor in guinea pigs and rats and its inhibition by a platelet-activating factor receptor antagonist Laboratory Investigation; a Journal of Technical Methods and Pathology 52(6): 617-630
Issekutz, A.C.; Szpejda, M. 1986: Evidence that platelet activating factor may mediate some acute inflammatory responses. Studies with the platelet-activating factor antagonist, CV3988 Laboratory Investigation; a Journal of Technical Methods and Pathology 54(3): 275-281
Floch, A.; Tahraoui, L.; Sedivy, P.; Cavero, I. 1991: The platelet activating factor receptor antagonist, RP 59227, blocks platelet activating factor receptors mediating liberation of reactive oxygen species in guinea pig macrophages and human polymorphonuclear leukocytes Journal of Pharmacology and Experimental Therapeutics 258(2): 567-575
Gereliuk, I.P.; Stukal, I.V. 1991: Disorders of plasma lipid spectrum, lysoform levels of platelet activating factor and blood platelet sensitivity to adrenaline in patients with stable stress-induced stenocardia Kardiologiia 31(1): 82-83
Cheng, D.; Chen, W.; Yang, X. 1996: The level of platelet activating factor in blood of rats with hypoxic pulmonary hypertension Hua Xi Yi Ke da Xue Xue Bao 27(2): 139-142
Cox, C.P.; Wardlow, M.L.; Jorgensen, R.; Farr, R.S. 1981: The presence of platelet-activating factor (PAF) in normal human mixed saliva Journal of Immunology 127(1): 46-50
Cromwell, O.; Wardlaw, A.J.; Champion, A.; Moqbel, R.; Osei, D.; Kay, A.B. 1990: IgG-dependent generation of platelet-activating factor by normal and low density human eosinophils Journal of Immunology 145(11): 3862-3868
Ostermann, G.; Rühling, K.; Zabel-Langhennig, R.; Winkler, L.; Schlag, B.; Till, U. 1987: Plasma from atherosclerotic patients exerts an increased degradation of platelet-activating factor Thrombosis Research 47(3): 279-285
Hofmann, B.; Meisgeier, U.; Kertscher, P.; Ostermann, G. 1988: Effects of synthetic analogues of platelet-activating factor (PAF) on fibrinolytic activity in the rat Biomedica Biochimica Acta 47(10-11): S161-S164
Seguchi, M.; Nakajima, S. 1995: Induction of ICAM-1 expression on the eosinophilic leukemia cell line-3 (EoL-3) by platelet-activating factor and platelet factor 4 Annals of Allergy Asthma and Immunology: Official Publication of the American College of Allergy Asthma and Immunology 74(3): 255-257
Robertson, D.A.; Wang, D.Y.; Lee, C.O.; Levi, R. 1988: Negative inotropic effect of platelet-activating factor: association with a decrease in intracellular sodium activity Journal of Pharmacology and Experimental Therapeutics 245(1): 124-128
Nolte, D. 1989: Platelet activating factor produces platelet activating factor, comes to nothing Medizinische Klinik 84(6): 319-320
O'Donnell, S.R.; Erjefält, I.; Persson, C.G. 1990: Early and late tracheobronchial plasma exudation by platelet-activating factor administered to the airway mucosal surface in guinea pigs: effects of WEB 2086 and enprofylline Journal of Pharmacology and Experimental Therapeutics 254(1): 65-70
Swierszcz, J.; Dubiel, J.S.; Milewicz, T.; Sztefko, K.; Galicka-Latała, D.; Pfitzner, R.; Wodniecki, J.; Krzysiek, Józef. 2010: One year observation of natural course of aortic valve stenosis in patients with normal and abnormal lipoprotein (a) plasma level Przeglad Lekarski 67(3): 161-164
Macpherson, J.L.; Kemp, A.; Rogers, M.; Mallet, A.I.; Toia, R.F.; Spur, B.; Earl, J.W.; Chesterman, C.N.; Krilis, S.A. 1989: Occurrence of platelet-activating factor (PAF) and an endogenous inhibitor of platelet aggregation in diffuse cutaneous mastocytosis Clinical and Experimental Immunology 77(3): 391-396
Peake, M.J.; Pejakovic, M.; Alderman, M.J.; Penberthy, L.A.; Walmsley, R.N. 1984: Mechanism of platelet interference with measurement of lactate dehydrogenase activity in plasma Clinical Chemistry 30(4): 518-520